Future studies on human pan-miRNA expression profiles, especially miRNAs that regulate hypertrophy, will be useful in determining the molecular impact of artificial Nrf2 enhancement on the potential pathogenesis of cardiomyopathy. Here, NFE2L2 is linked to cardiomyopathy.